Cargando…

Animal Models in the Pathophysiology of Cystic Fibrosis

Our understanding of the multiorgan pathology of cystic fibrosis (CF) has improved impressively during the last decades, but we still lack a full comprehension of the disease progression. Animal models have greatly contributed to the elucidation of specific mechanisms involved in CF pathophysiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Semaniakou, Anna, Croll, Roger P., Chappe, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328443/
https://www.ncbi.nlm.nih.gov/pubmed/30662403
http://dx.doi.org/10.3389/fphar.2018.01475
_version_ 1783386640990863360
author Semaniakou, Anna
Croll, Roger P.
Chappe, Valerie
author_facet Semaniakou, Anna
Croll, Roger P.
Chappe, Valerie
author_sort Semaniakou, Anna
collection PubMed
description Our understanding of the multiorgan pathology of cystic fibrosis (CF) has improved impressively during the last decades, but we still lack a full comprehension of the disease progression. Animal models have greatly contributed to the elucidation of specific mechanisms involved in CF pathophysiology and the development of new therapies. Soon after the cloning of the CF transmembrane conductance regulator (CFTR) gene in 1989, the first mouse model was generated and this model has dominated in vivo CF research ever since. Nonetheless, the failure of murine models to mirror human disease severity in the pancreas and lung has led to the generation of larger animal models such as pigs and ferrets. The following review presents and discusses data from the current animal models used in CF research.
format Online
Article
Text
id pubmed-6328443
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63284432019-01-18 Animal Models in the Pathophysiology of Cystic Fibrosis Semaniakou, Anna Croll, Roger P. Chappe, Valerie Front Pharmacol Pharmacology Our understanding of the multiorgan pathology of cystic fibrosis (CF) has improved impressively during the last decades, but we still lack a full comprehension of the disease progression. Animal models have greatly contributed to the elucidation of specific mechanisms involved in CF pathophysiology and the development of new therapies. Soon after the cloning of the CF transmembrane conductance regulator (CFTR) gene in 1989, the first mouse model was generated and this model has dominated in vivo CF research ever since. Nonetheless, the failure of murine models to mirror human disease severity in the pancreas and lung has led to the generation of larger animal models such as pigs and ferrets. The following review presents and discusses data from the current animal models used in CF research. Frontiers Media S.A. 2019-01-04 /pmc/articles/PMC6328443/ /pubmed/30662403 http://dx.doi.org/10.3389/fphar.2018.01475 Text en Copyright © 2019 Semaniakou, Croll and Chappe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Semaniakou, Anna
Croll, Roger P.
Chappe, Valerie
Animal Models in the Pathophysiology of Cystic Fibrosis
title Animal Models in the Pathophysiology of Cystic Fibrosis
title_full Animal Models in the Pathophysiology of Cystic Fibrosis
title_fullStr Animal Models in the Pathophysiology of Cystic Fibrosis
title_full_unstemmed Animal Models in the Pathophysiology of Cystic Fibrosis
title_short Animal Models in the Pathophysiology of Cystic Fibrosis
title_sort animal models in the pathophysiology of cystic fibrosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328443/
https://www.ncbi.nlm.nih.gov/pubmed/30662403
http://dx.doi.org/10.3389/fphar.2018.01475
work_keys_str_mv AT semaniakouanna animalmodelsinthepathophysiologyofcysticfibrosis
AT crollrogerp animalmodelsinthepathophysiologyofcysticfibrosis
AT chappevalerie animalmodelsinthepathophysiologyofcysticfibrosis